185 related articles for article (PubMed ID: 16298010)
1. Site specific gene delivery in the cardiovascular system.
Fishbein I; Stachelek SJ; Connolly JM; Wilensky RL; Alferiev I; Levy RJ
J Control Release; 2005 Dec; 109(1-3):37-48. PubMed ID: 16298010
[TBL] [Abstract][Full Text] [Related]
2. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
[TBL] [Abstract][Full Text] [Related]
3. Current status of catheter- and stent-based gene therapy.
Sharif F; Daly K; Crowley J; O'Brien T
Cardiovasc Res; 2004 Nov; 64(2):208-16. PubMed ID: 15485679
[TBL] [Abstract][Full Text] [Related]
4. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering therapy for cardiovascular disease.
Nugent HM; Edelman ER
Circ Res; 2003 May; 92(10):1068-78. PubMed ID: 12775655
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
7. Does gene therapy become pharmacotherapy?
Morishita R; Aoki M; Ogihara T
Exp Physiol; 2005 May; 90(3):307-13. PubMed ID: 15778409
[TBL] [Abstract][Full Text] [Related]
8. Modification of cardiovascular ion channels by gene therapy.
Telemaque S; Marsh JD
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):939-53. PubMed ID: 19673672
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
[TBL] [Abstract][Full Text] [Related]
10. Innate immune response induced by gene delivery vectors.
Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic prospects of cardiac gene transfer.
Kizana E
Heart Lung Circ; 2007 Jun; 16(3):180-4. PubMed ID: 17446126
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous methods of vector delivery in preclinical models.
Ladage D; Ishikawa K; Tilemann L; Müller-Ehmsen J; Kawase Y
Gene Ther; 2012 Jun; 19(6):637-41. PubMed ID: 22418064
[TBL] [Abstract][Full Text] [Related]
14. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
[TBL] [Abstract][Full Text] [Related]
15. Focal modification of electrical conduction in the heart by viral gene transfer.
Donahue JK; Heldman AW; Fraser H; McDonald AD; Miller JM; Rade JJ; Eschenhagen T; Marbán E
Nat Med; 2000 Dec; 6(12):1395-8. PubMed ID: 11100126
[TBL] [Abstract][Full Text] [Related]
16. Genetic therapies for cardiovascular diseases.
Melo LG; Pachori AS; Gnecchi M; Dzau VJ
Trends Mol Med; 2005 May; 11(5):240-50. PubMed ID: 15882612
[TBL] [Abstract][Full Text] [Related]
17. Airway gene therapy and cystic fibrosis.
Parsons DW
J Paediatr Child Health; 2005 Mar; 41(3):94-6. PubMed ID: 15790317
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors for gene therapy of heart disease.
Higuchi K; Medin JA
J Cardiol; 2007 Jan; 49(1):1-11. PubMed ID: 17269208
[TBL] [Abstract][Full Text] [Related]
20. Targeting the cell cycle machinery for the treatment of cardiovascular disease.
Bicknell KA; Surry EL; Brooks G
J Pharm Pharmacol; 2003 May; 55(5):571-91. PubMed ID: 12831500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
